Revision as of 18:50, 18 April 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{chembox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (← Previous edit | Revision as of 07:41, 21 April 2012 edit undoMSBOT (talk | contribs)13,809 editsm r2.7.3) (Robot: Adding fa:متیلندیاکسیمتوکسیاتیلآمفتامینNext edit → | ||
Line 41: | Line 41: | ||
{{Psychoactive-stub}} | {{Psychoactive-stub}} | ||
] |
Revision as of 07:41, 21 April 2012
Names | |
---|---|
IUPAC name 1-(1,3-benzodioxol-5-yl)-N-(2-methoxyethyl)propan-2-amine | |
Identifiers | |
CAS Number | |
3D model (JSmol) | |
CompTox Dashboard (EPA) | |
SMILES
| |
Properties | |
Chemical formula | C13H19NO3 |
Molar mass | 237.295 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Y verify (what is ?) Infobox references |
MDMEOET, or 3,4-methylenedioxy-N-methoxyethylamphetamine, is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N-methoxyethyl analogue of MDA. MDMEOET was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 180 mg. MDMEOET produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDMEOET.
See also
External links
This psychoactive drug-related article is a stub. You can help Misplaced Pages by expanding it. |